tiprankstipranks
Novo Integrated Sciences (NVOS)
OTHER OTC:NVOS
US Market
Want to see NVOS full AI Analyst Report?

Novo Integrated Sciences (NVOS) Price & Analysis

245 Followers

NVOS Stock Chart & Stats

$0.06
<$0.01(4.44%)
At close: 4:00 PM EST
$0.06
<$0.01(4.44%)

Bulls Say, Bears Say

Bulls Say
Revenue GrowthConsistent revenue growth indicates expanding market reach and product adoption, which can support long-term business sustainability.
Conservative LeverageA low debt-to-equity ratio suggests conservative leverage, providing financial flexibility and reducing risk of financial distress.
Strategic PartnershipsStrategic partnerships enhance market presence and distribution channels, potentially driving revenue and market share growth.
Bears Say
Negative Profit MarginsNegative profit margins indicate operational inefficiencies and high costs, which can hinder profitability and long-term financial health.
Negative Cash FlowConsistently negative cash flow raises concerns about the company's ability to sustain operations without additional financing.
Declining Equity RatioA declining equity ratio reflects reduced financial stability, potentially limiting the company's ability to invest in growth opportunities.

Novo Integrated Sciences News

NVOS FAQ

What was Novo Integrated Sciences’s price range in the past 12 months?
Novo Integrated Sciences lowest stock price was <$0.01 and its highest was $0.06 in the past 12 months.
    What is Novo Integrated Sciences’s market cap?
    Novo Integrated Sciences’s market cap is $69.06K.
      When is Novo Integrated Sciences’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Novo Integrated Sciences’s earnings last quarter?
      Currently, no data Available
      Is Novo Integrated Sciences overvalued?
      According to Wall Street analysts Novo Integrated Sciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Novo Integrated Sciences pay dividends?
        Novo Integrated Sciences does not currently pay dividends.
        What is Novo Integrated Sciences’s EPS estimate?
        Novo Integrated Sciences’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Novo Integrated Sciences have?
        Novo Integrated Sciences has 19,730,247 shares outstanding.
          What happened to Novo Integrated Sciences’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Novo Integrated Sciences?
          Currently, no hedge funds are holding shares in NVOS
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Novo Integrated Sciences

            Novo Integrated Sciences, Inc. (NVOS) delivers a diverse array of primary healthcare services and related products through its two primary operational segments: Healthcare Services and Product Manufacturing and Development. The company's extensive service portfolio includes various therapeutic approaches such as physiotherapy, chiropractic care, manual manipulation, occupational therapy, and massage therapy. They also offer specialized treatments like acupuncture, functional dry needling, chiropody, and advanced rehabilitation for stroke, traumatic brain injuries, and other neurological conditions. Additionally, NVOS provides kinesiology, vestibular therapy, concussion management, and baseline testing, alongside unique programs like trauma-sensitive yoga and meditation for brain injury recovery and PTSD. Women's pelvic health, sports medicine, assistive device provision, dietetics, holistic nutrition, fall prevention education, sports team conditioning, and private personal training are also part of their offerings. Novo Integrated Sciences, Inc. is dedicated to the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of a wide range of orthopedic, musculoskeletal, sports injury, and neurological conditions. These services are provided across all age demographics, from pediatric and adult patients to geriatric populations. For older adults, the company offers comprehensive eldercare physiotherapy within long-term care homes, retirement communities, and through community-based home care. This includes group exercise classes and fall prevention initiatives, alongside services at outpatient clinics. Similarly, occupational therapy services for the elderly are extended to retirement communities and long-term care facilities. Beyond direct care, the company incorporates medical technology, offering telemedicine consultations and remote patient monitoring. It also actively develops and distributes bespoke health and wellness product solutions. NVOS operates a network of 16 wholly-owned clinics. Established in 2000, the company is headquartered in Bellevue, Washington, and operates as a subsidiary of ALMC-ASAP Holdings, Inc.

            Novo Integrated Sciences (NVOS) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            American Shared Hospital Services
            Concord Medical Services
            Cryo-Cell International
            P3 Health Partners
            Mobile-health Network Solutions Class A

            Ownership Overview

            0.07%99.93%
            Insiders
            Mutual Funds
            0.07% Other Institutional Investors
            99.93% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks